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DNA-dependent protein kinase (DNA-PK) orchestrates DNA repair by regulating access to breaks through autophosphoryla-
tions within two clusters of sites (ABCDE and PQR). Blocking ABCDE phosphorylation (by alanine mutation) imparts a domi-
nant negative effect, rendering cells hypersensitive to agents that cause DNA double-strand breaks. Here, a mutational approach
is used to address the mechanistic basis of this dominant negative effect. Blocking ABCDE phosphorylation hypersensitizes cells
to most types of DNA damage (base damage, cross-links, breaks, and damage induced by replication stress), suggesting that
DNA-PK binds DNA ends that result frommany DNA lesions and that blocking ABCDE phosphorylation sequesters these DNA
ends from other repair pathways. This dominant negative effect requires DNA-PK’s catalytic activity, as well as phosphorylation
of multiple (non-ABCDE) DNA-PK catalytic subunit (DNA-PKcs) sites. PSIPRED analysis indicates that the ABCDE sites are
located in the only contiguous extended region of this huge protein that is predicted to be disordered, suggesting a regulatory
role(s) and perhaps explaining the large impact ABCDE phosphorylation has on the enzyme’s function. Moreover, additional
sites in this disordered region contribute to the ABCDE cluster. These data, coupled with recent structural data, suggest a model
whereby early phosphorylations promote initiation of nonhomologous end joining (NHEJ), whereas ABCDE phosphorylations,
potentially located in a “hinge” region between the two domains, lead to regulated conformational changes that initially pro-
mote NHEJ and eventually disengage NHEJ.
Classical nonhomologous end joining (c-NHEJ) is the majorDNA double-strand break repair (DSBR) pathway in all ver-
tebrates and is active throughout the cell cycle (1, 2); another
important DSBR pathway, homologous recombination (HR), is
active only in the S and G2 phases of the cell cycle when a sister
chromatid is available as a repair template (2). If c-NHEJ is dis-
abled, DNA double-strand breaks (DSBs) can still be directly li-
gated by an alternative end joining pathway (a-NHEJ); although
a-NHEJ is slower and more error prone than c-NHEJ, joining via
a-NHEJ is still relatively efficient (3). VDJ recombination is the
site-specific DNA recombination process that facilitates assembly
of functional exons encoding the antigen binding domain of im-
munoglobulins and T cell receptors in developing lymphocytes. If
c-NHEJ is disabled, rejoining of VDJ intermediates is severely im-
paired because the breaks are restricted from joining by a-NHEJ
via a poorly understood mechanism (4).
The DNA-dependent protein kinase (DNA-PK) initiates the
process of c-NHEJ first by utilizing the regulatory DNA binding
subunit, Ku, to bind to DNA double-strand breaks (DSBs) and
then by regulating access to DSBs via a series of phosphorylations
mediated by the large catalytic subunit, DNA-PKcs. To date,more
than 60 serines and threonines (1.5% of the 4,128 residues) within
DNA-PKcs have been shown to be targeted (mostly) by DNA-
PKcs itself (5, 6). Of these 60 phosphorylation sites, 20 have
been studied bymutagenesis, and 16 of those were shown to affect
biological function (7–13). Of these 16 biologically relevant sites,
phosphorylations of three affect enzymatic activity. Phosphoryla-
tions of the remaining 13 sites do not affect enzymatic activity.
Blocking phosphorylation of some sites results in a radiosensitive
phenotype, whereas at other sites, phosphomimicking results in
increased radiosensitivity. These data suggest that certain auto-
phosphorylations promote c-NHEJ (perhaps committingDSBs to
the c-NHEJ pathway) while other phosphorylations function to
disengage c-NHEJ, a beneficial outcome if DNA-PK were bound
to a DNA end that could (or should) not be joined by c-NHEJ (for
instance, an intermediate generated by repair of a DNA interstrand
cross-link or a DNA end that results from replication fork arrest).
We have shown previously that autophosphorylation within
two major clusters reciprocally regulates DNA end processing
during c-NHEJ (10). Phosphorylation within the ABCDE cluster
(including six sites between residues 2609 and 2647) promotes
DNA end processing, whereas phosphorylation within the PQR
cluster (including five sites between residues 2023 and 2056) limits
end processing. This reciprocal regulation of end processing was
surmised by sequencing repaired DSBs from cells expressing
DNA-PKcs that could not be phosphorylated at either the ABCDE
or PQR sites (10). Consistent with this interpretation, a mutant
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with all six ABCDE sites converted to alanines (ABCDEAla)
blocksDNA end access in vitro to a variety of enzymes (14, 15) and
cannot activate the Artemis nuclease (16). Although phosphory-
lation of the ABCDE sites clearly promotes kinase dissociation
(17), ABCDE phosphorylation is neither necessary nor sufficient
for kinase dissociation; we have suggested that phosphorylation of
additional sites (likely in conjunction with ABCDE phosphoryla-
tion) facilitates disassembly of the complex, underscoring the
complexities of how c-NHEJ is regulated by DNA-PK. Although
studies from our laboratories demonstrate that phosphorylations
within the ABCDE cluster are predominately autophosphoryla-
tions (18), other investigators have concluded that ATM or ATR
targets these sites (19, 20).
Unlike any other DNA-PKcs mutation studied to date, block-
ade of ABCDE phosphorylation by mutation results in a severe
cellular phenotype, consistent with ABCDEAla exerting a dom-
inant negative effect on other DSB repair pathways. In fact, ex-
pressing the ABCDEAlamutant renders cells hypersensitive to a
variety of DNA damaging agents including ionizing radiation
(IR), etoposide, mitomycin C, zeocin, hydroxyurea (HU), methyl
methanesulfonate (MMS), UV, cisplatin, and camptothecin (Fig.
1) (21). Recent studies from Zhang and colleagues, where alanine
substitutions were introduced at three of these sites in the mouse
genome, support the conclusion that this mutant exerts a strong
dominant negative effect on alternative DSB repair pathways (8).
Notably, the most striking phenotype of this mouse was hemato-
logic failure from replication stress; thus, the data presented here
showing strong cellular phenotypes with agents that disrupt rep-
lication are consistent with DNA-PK binding DNA ends that re-
sult from replication stress.Here, using amutational approach,we
further characterize the mechanistic basis of the severe phenotype
imparted by blocking phosphorylation of the ABCDE cluster in
DNA-PKcs. We show that DNA-PK’s catalytic activity is re-
quired for the dominant negative phenotype imparted by the
ABCDEAla mutant and that phosphorylation of several other
amino acids within DNA-PKcs is also necessary to elicit this phe-
notype. These data, coupled with emerging structural data, pro-
vide insight into how DNA-PK’s autophosphorylation functions
to regulate c-NHEJ.
MATERIALS AND METHODS
Expression plasmids.The expression constructs forwild-type (wt)DNA-
PKcs, the K3753R mutant, the ABCDE(T2609, S2612, T2620, S2624,
T2638, T2647)Ala mutant (where each residue is replaced with an
alanine), and the ABCDEPQR(S2023, S2029, S2041, S2053,
S2056)M(S3205)Ala (with alanine substitutions at the PQR and M
sites indicated) mutant have been previously described (9, 22, 23). To
generate the additional combinationmutants, restriction fragments from
the K3753R expression plasmid (PmlI-XmaI), theM(S3205)Ala plas-
mid (11) (FseI-PmlI) the JK(T946, S1004)Ala expression plasmid (11)
(NarI-NarI), the T(T3950)Ala expression plasmid (17) (PmlI-XmaI),
and the N(S56, S72)Ala expression plasmid (11) (MluI-BstZ17I) were
subcloned into the corresponding sites in the ABCDEAla expression
plasmid. All mutations were confirmed by sequence analysis.
The ABCDEEXTFGAla mutant was generated by synthesizing a
fragment spanning the AgeI (residue 7608) to the FseI (8160) site by
multiplex PCR. This fragment included a total of 18 Ser/ThrAla substi-
tutions at the following amino acids: ABCDEEXT sites S2599, T2600,
T2603, T2609, S2612, T2615, T2620, S2624, T2638, T2645, T2647, and
T2649; FG sites S2655, T2671, S2672, S2674, S2675, and S2677. The SalI
site in wild-type DNA-PKcs at residue 8000 was ablated in this fragment,
and a new SalI site was introduced in front of AgeI. This fragment was
subcloned into the DNA-PKcs expression vector using SalI and FseI. To
generate the ABCDEEXTAla and FGAla mutants, the fragment con-
taining all 18 Ser/ThrAla mutations was restricted with PstI (residue
7948), and each combination was generated. To facilitate cloning, the
ABCDEEXTAla and FGAla mutants were constructed in a much
smaller, low-copy-number expression plasmid utilizing the CAGG pro-
moter; thus, independent wild-type, ABCDEAla, and vector cell strains
were also generated using this expression construct.
Cell culture and cell strains. Cells were cultured in minimum essen-
tial medium alpha (Gibco) with 10% fetal calf serum, 100U/ml penicillin,
100g/ml streptomycin, and 10g/ml ciprofloxacin (completemedium)
andmaintained at 37°Cwith 5%CO2.Methods to derive V3 transfectants
have been previously described (11). Briefly, the DNA-PKcs-deficient
Chinese hamster ovary cell line used as the parental cell strain, designated
V3-CFP, was cotransfected with the DNA-PKcs expression plasmid indi-
cated in the figure legends, and the pSuper.puro plasmid, to confer puro-
mycin resistance, using FuGENE 6 (Roche) according to the manufactur-
er’s instructions. Independent, stable transfectants were selected and
maintained in complete medium containing 10 g/ml puromycin. At
least two independently derived clones expressing eachmutant were stud-
ied and are presented in Fig. 3 and 5 to 8. For clonogenic assays presented
in Fig. 1, only one clone is presented to simplify the figure; however, at
least two clones expressing each mutant were studied with completely
analogous results.
Immunoblotting and DSB-induced nuclear mobilization. Unless
otherwise indicated, whole-cell extracts were generated by resuspending
cell pellets in solubilization buffer (50 mMHEPES [pH 7.5], 50 mMNaF,
5 mM MnCl2, 0.1% Triton X-100, 3 mg/ml DNase I, with protease and
phosphatase inhibitors) and incubation at 37°C for 5 min. DNA-PKcs
protein levels were analyzed after electrophoresis on 5% SDS-polyacryl-
amide gels and transfer to polyvinylidene difluoride membranes. To de-
tect total DNA-PKcs, a monoclonal antibody raised against DNA-PKcs
(42-27; a generous gift of TimCarter, St. JohnsUniversity, NewYork,NY)
was used as the primary antibody. For detection of DNA-PKcs or H2AX
following cisplatin exposure, cells were treated with cisplatin and allowed
various amounts of time to repair, as described below. DNA-PKcs or
H2AX protein levels were analyzed in whole-cell extracts by immuno-
blotting using a primary antibody that recognizes either DNA-PKcs or
H2AX (Millipore).
To visualize nuclear mobilization of DNA-PKcs in response to DSBs,
V3 transfectant strains were treated (or not) with 2 mg/ml zeocin in the
absence of serum and antibiotics for 1 h at 37°C with 5% CO2. Cells were
harvested immediately after treatment or after 24 h of culture in fresh
medium. A Triton-insoluble nuclear fraction was isolated as previously
described (24) and analyzed by immunoblotting using primary antibodies
that recognize either DNA-PKcs phospho-S2056 (Abcam), lamin B
(Santa Cruz), or H2AX (Millipore).
Clonogenic survival assays. For cells treated with zeocin, camptoth-
ecin, HU, cisplatin, MMS, and vincristine, V3 transfectants were plated at
cloning densities into complete medium containing the dosages of the
appropriate agent indicated in the figures. For HU and camptothecin, 24
h after treatment the medium containing the damaging agent was re-
moved, and cells were replenished with fresh culture medium. For UV
exposure, cells were plated at cloning density in complete medium and
allowed 5 h to attach. The cells were washed with phosphate-buffered
saline (PBS) and then irradiated with the doses of 254-nm UV (UV254)
indicated in the figures. For all agents, after 7 days cell colonies were
stained with 1% (wt/vol) crystal violet in ethanol, and colony numbers
were assessed. Survival was plotted as percent survival compared to un-
treated cells.
VDJ recombination assays. Extrachromosomal VDJ recombination
assays were performed utilizing a coding joint substrate (pJH290) and
signal joint substrate (pJH201) as described previously (25). Briefly, V3
cells were plated into 60-mm-diameter dishes and transiently transfected
with 1 g of substrate, 6 g of wild-type or a mutant form of DNA-PKcs
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or pCMV6 vector, and 2 g each of RAG1 and RAG2 using FuGENE 6
transfection reagent. Forty-eight hours after transfection, substrate plas-
mids were isolated by alkaline lysis and subjected to DpnI digestion for 1
h. DpnI-digested DNA was transformed into competent DH5 cells (In-
vitrogen, Carlsbad, CA) according to the manufacturer’s instructions.
Transformed cells were spread onto LB agar plates containing 100 g/ml
ampicillin only or 100 g/ml ampicillin and 22 g/ml chloramphenicol.
The percentage of recombination was calculated as the number of colo-
nies resistant to ampicillin and chloramphenicol divided by the number of
colonies resistant to ampicillin. Plasmid DNA from recombined pJH290
(coding joints) was isolated and sequenced at Michigan State University’s
core DNA sequencing facility.
FIG 1 Blocking phosphorylation at the ABCDE sites sensitizes cells to many agents that damage DNA but not to an agent that disrupts microtubules. V3
transfectants expressing wild-type DNA-PKcs (wt strain 52), the catalytically inactive K3753R mutant (KR strain 5), the ABCDEAla cluster mutant
(ABCDEA strain 7), or no DNA-PKcs (vector strain 5) were plated at cloning densities into complete medium with increasing doses of the indicated
DNA-damaging agent or the microtubule-destabilizing agent, vincristine. Colonies were stained after 7 days, and percent survival was calculated. Error bars
represent the standard error of the means. Two independent cell strains were tested for each DNA-PKcs variant with similar results; one representative strain of
each variant is presented here. DNA-PKcs protein expression levels of untreated cells were examined byWestern blotting of whole-cell extracts obtained from the
indicated cell strains (bottom, right).
Neal et al.
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Detection of cisplatin adducts in genomic DNA.Cells were plated at
a density of 1  106 cells per well into six-well plates containing 2 ml of
complete medium and allowed to grow for 24 h at 37°C with 5% CO2.
Cells were treated with 10 M cisplatin, or no cisplatin, for 2 h at 37°C
with 5% CO2. After 2 h, the medium containing cisplatin was removed,
and cells were washed with PBS and then replenished with fresh culture
medium. Cells were allowed to repair for 0, 1, 2, 4, 24, and 48 h at 37°C
with 5% CO2. DNA was extracted from cells by lysis in the well and
spooling as described by Laird et al. (26). DNA (30 to 50 g) was hydro-
lyzed overnight in 1%nitric acid at 70°C in a 500-l total volume. Samples
were diluted to a 1.5-ml final volume in 1% nitric acid and analyzed by
inductively coupled plasma-mass spectrometry (ICP-MS). A benchtop
series Thermo ICPMS X-series II system with collision cell technology
(CCT) capability and PlasmaLab software were used to quantify the plat-
inum concentrations. The argon (Ar) plasma torch purity was at least
99.999% (Praxair Distribution, Inc.). Water was purified with a Milli-Q
Advantage A10 System (Millipore). Optima nitric acid 67 to 70% (Fisher
Scientific) was diluted to 2% and used as the solventmatrix while certified
standard solutionswere provided by InorganicVentures. ICP-MS calibra-
tion was conducted according to the manufacturer’s specifications, fol-
lowed by a multipoint curve fitted by linear regression with a minimum
correlation coefficient (R2) of 0.999.
Computational analyses of DNA-PKcs. Prediction of the secondary
and tertiary structures was carried out using the PSIPRED (27) and
HHpred (28) servers using the primary amino acid sequence of DNA-
PKcs as the input query. Regions predicted as primarily disordered were
assigned based on a lack of domain homology detection by HHpred and
supported by a prediction of random coil by the PSIPRED server. Chain
trajectory was estimated based on prior assignments of the N terminus,
the HEAT repeats within the ring domain, and the kinase domain by
Sibanda et al. (29).
RESULTS
Blocking DNA-PK’s ABCDE phosphorylation hypersensitizes
cells to many different DNA damaging agents.We showed pre-
viously that both hamster and mouse cells stably expressing hu-
man DNA-PKcs in which the ABCDE sites cannot be phosphory-
lated are hypersensitive to IR, mitomycin C, and etoposide (21).
Recently DNA-PK has also been implicated in other repair pro-
cesses (for instance, the response to replication stress) (30). We
asked whether blocking ABCDE phosphorylation affected cell
survival in the presence of additional agents that induce a variety
of different types of DNA damage. As can be seen in Fig. 1, V3
clonal transfectants stably expressing theABCDEAlamutant are
more sensitive to camptothecin, HU, cisplatin, UV, MMS, and
zeocin than V3 clonal transfectants expressing a catalytically inac-
tive K3753R variant of DNA-PKcs or noDNA-PKcs at all. All of
these agents induce cell death by eliciting different types of DNA
damage. We also tested cellular sensitivity to vincristine, which
does not damage DNA but causes cell death by disrupting micro-
tubules; all cell types are similarly sensitive to vincristine.We con-
clude that blocking ABCDE phosphorylation hypersensitizes cells
to many DNA damaging agents that cause a variety of types of
DNA lesions.
Blocking DNA-PK’s ABCDE phosphorylation impairs re-
moval of cisplatin adducts from DNA. We considered two pos-
sibilities to explain why blocking ABCDE phosphorylations
hypersensitizes cells toDNAdamage: (i) the ABCDEAlamutant
blocks access to DNA ends (that are generated during repair of a
variety of different lesions) by other repair pathways (HR or a-
NHEJ), or (ii) the ABCDEAla mutant induces cell death by in-
appropriate signaling. We reasoned that if the ABCDEAla mu-
tant blocked repair by other pathways, DNA damage should be
retained longer. Unlike damage induced by irradiation, some
DNAdamaging agents generate covalent adducts inDNA that can
be measured by physical means. Cisplatin adducts are readily
measured by mass spectrometry (ICP-MS methodology). To ad-
dresswhetherDNAdamagewas retained longer in cells expressing
the ABCDEAla mutant, removal of adducts from the DNA of
cells treated with cisplatin was measured. Removal of cisplatin
adducts in cells expressing the ABCDEAla mutant was delayed
by approximately 24 h (Fig. 2A). Longer persistence of cisplatin
adducts would be consistent with the ABCDEAlamutant block-
ing access of DNA ends to other repair pathways (as opposed to
inducing inappropriate signaling). It should be noted that cells
expressing wild-type DNA-PKcs removed cisplatin-DNA adducts
just slightly more slowly than cells expressing no DNA-PKcs. This
is consistent with studies showing that DNA-PKcs-deficient cells
often display reduced sensitivity to cross-linking agents (21, 31);
this is observed inV3 transfectants at higher doses of cisplatin, and
the increased sensitivity is dependent on DNA-PKcs expression
levels (K. Meek, unpublished data).
Repair of interstrand DNA cross-links involves incisions on
either side of the cross-link (“unhooking”) by nucleotide excision
repair (NER) followed by translesion synthesis and/or recombi-
national repair. The ability of DNA-PK to oppose HR is well ap-
preciated (11), and since HR is initiated by DSBs, it seems that the
HR pathway may be the most likely impacted by ABCDEAla
during repair of cisplatin-induced damage. We considered that
the increased cisplatin sensitivity might also result in increased
accumulation of DSBs (because the repair of DSBs is blocked by
the presence of ABCDEAla); H2AX levels weremeasured as an
indicator of persistent DSBs. Whereas cells lacking DNA-PKcs
have only a minimal increase in H2AX after cisplatin damage
(consistent with rapid removal of the lesions), cells expressing
wild-type DNA-PKcs have a more pronounced, but transient, in-
crease in H2AX. In contrast, the levels of H2AX in cisplatin-
treated cells expressing the ABCDEAla mutant are higher and
more sustained than in cells expressing wild-type DNA-PKcs or
no DNA-PKcs, consistent with the presence of unrepaired DSBs
(Fig. 2B). DNA-PKcs itself is actually a well-studied target of
caspase 3 and the apoptotic cascade (32, 33). Thus, DNA-PKcs
levels weremeasured (as an indirect measure of apoptosis) in cells
expressing wild-type DNA-PKcs or the ABCDEAla mutant for
48 h after cisplatin exposure. As can be seen, DNA-PKcs levels are
not changed, and no evidence of DNA-PKcs cleavage is observed
(Fig. 2C). These data suggest that the ABCDEAla mutant exerts
its dominant negative effect, at least with respect to repair of cis-
platin adducts, by blocking access of the HR pathway to DNA
ends.
Enzymatic activity is required for theABCDEdominantneg-
ative effect. In an effort to understand the molecular basis of the
ABCDE dominant negative effect, we first determined whether
DNA-PK’s catalytic activity is required for its ability to blockDNA
end access to other repair factors. To that end, a mutant was gen-
erated and characterized that combined the ABCDEAla and the
kinase-inactivating K3753R mutations (Fig. 3); two indepen-
dent V3 clones stably expressing each construct were isolated and
studied. Whereas wild-type DNA-PKcs reverses the zeocin-sensi-
tive phenotype of V3 cells, the ABCDEAla mutant dramatically
worsens this phenotype. In contrast, zeocin sensitivity of the com-
bined mutations, ABCDEAlaK3753R, is analogous to that
of cells that completely lack DNA-PKcs, indicating that DNA-
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FIG 2 Blocking phosphorylation at the ABCDE sites decreases the rate at which cells remove cisplatin. (A) V3 transfectants expressing wild-type
DNA-PKcs (wt strain 59), the ABCDEAla mutant (strain 7), or no DNA-PKcs (vector strain 5) were treated with 10 M cisplatin for 2 h and then allowed 0,
1, 2, 4, 24, or 48 h to repair. The percentage of platinum adducts remaining in the genomic DNA was then analyzed by ICP-mass spectrometry. The inset shows
an expanded view of the 0-, 1-, 2-, and 4-h time points. Error bars represent the standard errors of the means. (B) V3 transfectants expressing
Neal et al.
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PK’s enzymatic activity is required for the ABCDEAla dominant
negative phenotype.
Each mutant was also tested for its ability to complement the
VDJ recombination defects associated with DNA-PKcs deficiency
utilizing an episomal assay developed by Hesse and colleagues
(25). Although cells expressing the ABCDEAla mutant are re-
markably more sensitive to zeocin than cells expressing no DNA-
PKcs, both VDJ coding and signal end joining are consistently
increased in cells expressing the ABCDEAla mutant compared
to cells that lack DNA-PKcs (9) (Fig. 3B); this may seem counter-
intuitive. However, whereas clonogenic survival indirectly mea-
sures the cells’ capacity to repair DSBs induced by zeocin using all
DSB repair pathways (HR, a-NHEJ, and c-NHEJ), repair of VDJ
recombination intermediates can only be mediated by c-NHEJ.
This is because recombination-activating gene (RAG)-induced
breaks, i.e., VDJ recombination intermediates, are blocked from
a-NHEJ although the mechanisms are poorly understood (4, 34).
Thus, the low levels of VDJ joining indicate that cells expressing
the ABCDEAla mutant can execute a minimal level of c-NHEJ.
We suggest that the ABCDEAla mutant initiates c-NHEJ, form-
ing a functional c-NHEJ complex, but progress of repair is im-
paired perhaps because ABCDE phosphorylation is required to
initiate end processing. The impaired c-NHEJ mediated by the
ABCDEAla mutant might also block access of the DSB to other
repair pathways (HR or perhaps a-NHEJ), resulting in hypersen-
sitivity to zeocin of cells expressing this mutant.
Evidence that ABCDE is present in an unstructured region.
Implicit in the finding that kinase activity is required for the
ABCDE dominant negative effect is that another phosphorylation
event or events are required to inhibit access of DNA ends to other
repair pathways. Our previous studies have shown that, in many
cases, phosphorylations of DNA-PKcs itself are functionally rele-
vant; thus we next focused on determining whether other DNA-
PKcs phosphorylations are required for the ABCDE dominant
negative effect. To facilitate interpretation of these data, it is help-
ful to understand relative positions of the phosphorylation sites
within the DNA-PK complex. Figure 4A depicts the phosphoryla-
tion sites studied previously and summarizes phenotypes associ-
ated with each phosphorylation site mutant using both cellular
and biochemical assays (9–11, 14, 15, 17, 18, 21, 22, 35, 36). Table
S1 in the supplemental material also defines every phosphoryla-
tion site studied.
Structure/function studies of the DNA-PK complex have been
hampered by a lack of high-resolution structural information. A
low-resolution crystal structure at 6.6 Å of DNA-PKcs has been
reported (29). The resolution of the structure allows only a rough
estimation of the overall shape of the molecule. Importantly, this
low-resolution crystal structure shares many features with previ-
ous cryo-electron microscopy (cryo-EM) structures of DNA-PK
(37–40) and with solution structures recently reported using
small-angle X-ray scattering (SAXS) techniques (5, 41).
The modeled structure includes seven distinct regions (29)
(Fig. 4B). The phosphatidylinositol 3-kinase (PI3K) domain is
shown in yellow and is positioned in the domain termed the head
domain in cryo-EM studies. The FAT and FATC domains are
magenta. The ring-shaped structures (shown in green) derive
from the N terminus (also referred to as the palm domain in pre-
vious studies). The ring structure is comprised entirely of HEAT
repeats and has a gap at the base. The authors speculated thatDNA
is threaded through the gap at the base of the ring. The ring is
concave (or cradle shaped) when viewed from the side. Sibanda et
al. proposed a DNA binding pocket (cyan).
We performed secondary-structure analysis using PSIPRED
(27) and searched for domain homologies using HHpred (28).
wild-type DNA-PKcs, the ABCDEAla mutant, or no DNA-PKcs (vector) were treated with 10 M cisplatin for 2 h and then allowed 4, 24, or 48 h to repair.
Whole-cell extracts were analyzed by Western blotting for the level of H2AX expression. The level of 	-actin expression was used as a loading control. One of
three independent experiments performed with identical results is depicted. (C) V3 transfectants expressing wild-type DNA-PKcs or the ABCDEAla mutant
were treated with 10 M cisplatin for 2 h and then allowed 0, 1, 2, 4, 24, or 48 h to repair. Whole-cell extracts were analyzed by Western blotting for the level of
DNA-PKcs expression. One of two independent experiments performed with identical results is depicted.
FIG 3 Enzymatic activity is required for the ABCDEAla phenotype. (A)
Two independent V3 transfectant cell strains expressing wild-type DNA-PKcs
(wt strains 52 and 59), the ABCDEAla mutant (strains 7 and 10), the
ABCDEAlaK3753R combinationmutant (strains 6 and 12), or noDNA-
PKcs (vector strains 5 and 6) were plated at cloning densities into complete
medium containing increasing doses of zeocin as indicated. Colonies were
stained after 7 days, and percent survival was calculated. Error bars repre-
sent standard error of the means. The inset shows the level of DNA-PKcs
protein expression in untreated cells as determined by Western blotting of
whole-cell extracts obtained from the indicated cell strains. (B) Recombina-
tion percentage of the coding joint substrate pJH290 or signal joint substrate
pJH201 in V3 cells transiently expressing RAG proteins and either wild-type
DNA-PKcs, the ABCDEAla mutant, the ABCDEAlaK375R combina-
tion mutant, or no DNA-PKcs. Error bars represent the standard error of the
means. Note that the differences between the recombination efficiencies of the
ABCDEAla and the ABCDEAlaK3753Rmutants for both coding end
joining (P 0.05) and signal end joining (P 0.01) are statistically significant
based on a two-tailed unpaired t test.
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With this information, we attempted to trace the primary amino
acid sequence onto the structure and to assign the seven regions
including 2,032 residues to specific regions inDNA-PKcs. Sibanda
et al. assigned the N terminus to the gap at the base of the ring
domain. The polypeptide can be traced from the base of the ring,
counterclockwise, toward the forehead or brow. Then, the most
likely trajectory is for the chain to continue counterclockwise
down toward the base of the ring. Upon reaching the gap formed
with the N terminus, the protein appears to reverse its trajectory,
moving up toward the FAT domain. The trace ends at the kinase
domain. An estimation of the location of the sites studied here is
shown in Fig. 4B: N sites are at the N-terminal base of the ring
domain, JK sitesare in the ring domain, the PQR cluster is in the
ring domain, perhaps close to the putative DNA binding pocket,
the M site is in the FAT domain, the T site is in the PI3K domain,
and the catalytic K3753 and D3922 residues are in the PI3K do-
main. Importantly, the ABCDE sites cannot be positioned in any
of these chains. PSIPRED returns its secondary-structure predic-
tions with a score between 0 and 9, reflecting the confidence of the
prediction. The region encompassing residues 2500 to 2700 in-
cluding the ABCDE phosphorylation cluster is predicted to be
entirely disordered with only one short sequence predicted to be
helical (6 residues), and that prediction is with low confidence
(scores of 0 to 3). In sum, the PSIPREDanalysis indicated a greater
than 75% likelihood for lack of secondary structure in this region.
Moreover, HHpred searches of this region with existing protein
structures yielded no significant matches for secondary structure.
Intrinsically disordered segments in proteins are often regions
found to be critical for important biologic functions (42). Al-
though the ABCDE cluster is in a region absent in the crystal
structure, from modeling regions adjacent in the primary se-
quence, it can be assumed that the ABCDE cluster is likely to be
located at a hinge-like region between the head domain (FAT/
kinase/FATC) and the large ring domain. Dobbs et al. also sug-
gested that the ABCDE phosphorylation sites are in this region
(5). Although the placement of these phosphorylation targets is
only an estimation, we reasoned that having even a rough estima-
tion of the spatial positions of different phosphorylation targets
might facilitate data interpretation. It is interesting that similar
computational analyses with ATR and ATM did not predict any
extensive areas of random coil in either polypeptide compared to
DNA-PKcs.
To address if (and which) additional phosphorylations
might be required for the dominant negative phenotype of the
ABCDEAla mutant, alanine blocking mutations of 11 previ-
ously studied DNA-PKcs phosphorylation sites (depicted in
Fig. 4A and listed in Table S1 in the supplemental material)
were introduced into the expression construct encoding the
ABCDEAla mutant and characterized functionally. All of these
alanine mutants, as well as all combination mutants studied be-
low, retained full enzymatic activity (see Fig. S1 in the supplemen-
tal material). Since these assays require DNA-PKcs assembly onto
Ku-boundDNA, enzymatic activity strongly suggests that themu-
tants can assemble onto Ku-bound DNA. To confirm that the
enzymatic activity is dependent on Ku–DNA-PKcs interactions,
enzymatic activity was also assessed in an xrs6 cell transfectant
(which lacks Ku86) expressing human DNA-PKcs. As expected,
even though high levels of DNA-PKcs are expressed, in the ab-
sence of Ku, no enzymatic activity was detected (see Fig. S1).
BlockingphosphorylationofS3205 (anATMtarget)doesnot
alter the ABCDE>Ala phenotype. We have previously defined
S3205, referred to as siteM, as an in vitroDNA-PK autophosphor-
ylation site (36) and studied this site in conjunction with the
ABCDE, PQR, and T3950 sites, but not with ABCDEAla substi-
tutions alone. This S/hydrophobic site is strongly conserved in
vertebrate DNA-PKcs and has been identified as an in vivo phos-
phorylation site in numerous genome-wide phosphoproteomics
screens (reviewed in reference 5). More recently, S3205 was iden-
tified as an IR-induced phosphorylation site in a genome-wide
analysis of sites phosphorylated in theDNAdamage response (43)
and as an ATM target in response to DNA damage (44). As can be
seen in Fig. 5, two independent clones expressing the combined
ABCDEMAla mutant behave indistinguishably from
ABCDEAla transfectants in zeocin clonogenic survival assays
and VDJ recombination assays. Moreover, sequence analysis of
coding joints in cells expressing ABCDEMAla show severely
restricted end processing, analogous to joints mediated by the
FIG 4 Current Model of DNA-PKcs. (A) Schematic of DNA-PKcs polypep-
tide showing the position of previously studied phosphorylation (P) sites; the
kinase domain is shaded blue, and phosphorylation sites are denoted by aster-
isks (N, S56 and S72; JK, T946 and S1004; PQR, S2023, S2029, S2041, S2053,
and S2056; ABCDE, T2609, S2612, T2620, S2624, T2638, and T2647; M,
S3205). (B)Molecular surface of DNA-PKcs (29) showing seven regions of the
DNA-PKcs polypeptide including an approximation of the positions of the
phosphorylation sites and catalytic site (K3753) studied here, as determined by
PSIPRED analysis.
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ABCDEAla mutant (Table 1). We conclude that phosphoryla-
tion of S3205 does not affect the phenotype imparted by express-
ing the ABCDEAla mutant.
Phosphorylation of sites potentially adjacent to the DNA
binding pocket is required for the ABCDE>Ala dominant neg-
ative phenotype. In the proposed structural model, when the ki-
nase is viewed from the side (Fig. 4B), one can appreciate that the
PQR/JK and ABCDE sitesmay be adjacent to the region where the
head and ring domains intersect (with the PQR sites being posi-
tioned in the putative DNA binding pocket and the JK sites just
above). It is worth noting that our previous studies (10) have
shown that phosphomimicking the PQR sites results in severe
restriction of end processing while maintaining robust NHEJ ca-
pacity. This is conceptually consistent with amodel whereby PQR
phosphorylation promotes DNA end binding and limits end ac-
cess to other factors. We have previously partially characterized a
combined ABCDEPQRMAla mutant (10). As can be seen,
cells expressing the combined ABCDEPQRMAla or the
ABCDEJKAla mutant are more resistant to zeocin than cells
expressing the ABCDEAlamutant (Fig. 6). In contrast, themin-
imal coding end and signal end joining of the ABCDEAla mu-
tant is completely ablated by blocking PQRphosphorylation; cod-
ing end joining (but not signal end joining) is also partially
abrogated by blocking JK phosphorylation. Sequence analysis of
rare coding joints in cells expressing ABCDEPQRMAla
show that the severe restriction of end processing imparted by the
ABCDEAla mutant is reversed by blocking PQR phosphoryla-
tion (Table 1). This is consistent with our previous characteriza-
tion of the PQRAlamutant, which allows extensive end process-
ing. The severe restriction of end processing by blocking ABCDE
phosphorylation is also reversed in the ABCDEJKAlamutant;
however, in this case end processing levels are returned to wild-type
levels. The JKAlamutant does not affect endprocessing on its own,
but phospho-mimicking these sites strongly impedes c-NHEJ (11).
Although other explanations are possible, the differences in VDJ re-
combination efficiency between ABCDEPQRMAla and
ABCDEJKAla may be a reflection of the dependence on PQR
phosphorylation for efficient c-NHEJ versus JK phosphorylation,
which inhibits c-NHEJ (11). Experiments investigating the basis
for these differences are ongoing. However, we interpret this re-
duction in VDJ joining for both of these combined mutants as
evidence of reduced c-NHEJ.We suggest that the reduced c-NHEJ
(by blocking PQR and JK phosphorylation) may allow increased
FIG 5 Blocking phosphorylation of the M site does not alter the ABCDE
phenotype. (A) Two independent V3 transfectant cell strains expressing wild
typeDNA-PKcs (wt strains 52 and 59), the ABCDEAlamutant (strains 7 and
10), the ABCDEMAla combinationmutant (strains 6 and 7)), or noDNA-
PKcs (vector strains 5 and 6) were plated at cloning densities into complete
medium containing increasing doses of zeocin as indicated. Colonies were
stained after 7 days, and percent survival was calculated. Error bars represent
the standard error of the means. The inset shows the level of DNA-PKcs pro-
tein expression in untreated cells as determined byWestern blotting of whole-
cell extracts obtained from the indicated cell strains. (B) Recombination per-
centage of the coding joint substrate pJH290 or signal joint substrate pJH201
in V3 cells transiently expressing RAG proteins and either wild-type DNA-
PKcs, the ABCDEAla mutant, the ABCDEMAla combination mutant,
or no DNA-PKcs. Error bars represent the standard error of the means. Note
that the differences between the recombination efficiencies of the
ABCDEAla and the ABCDEMAla mutants for both coding end joining
(P  0.05) and signal end joining (P  0.05) are not statistically significant
based on a two-tailed unpaired t test.














Wild type 43 4.95 4 34 (29/86) 44 (19/43) 14 (4/29)
ABCDEAla 37 2.97 1.0 62 (46/74) 11 (4/37) 11 (5/46)
ABCDEAlaK3753R 12 37.42 12.5 17 (4/24) 50 (6/12) 75 (3/4)
ABCDEMAla 38 1.18 1.0 68 (52/76) 5 (2/38) 31 (16/52)
ABCDEPQRMAla 33 20.91 8 30 (20/66) 39 (13/33) 50 (10/20)
ABCDEJKAla 36 4.78 3.0 49 (35/72) 22 (18/36) 31 (11/35)
ABCDENAla 42 2.36 1.5 60 (50/84) 17 (7/42) 36 (18/50)
ABCDETAla 33 8.15 4 44 (29/66) 39 (13/33) 31 (9/29)
ABCDEPQRMTAla 8 16.13 7.5 50 (8/16) 25 (2/8) 75 (6/8)
a Values in parentheses represent the number of intact coding ends/total number of ends.
b Values in parentheses represent the number of sequences with short sequence homology/total number of sequences.
c Values in parentheses represent the number of P segments/number of complete ends.
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access of DNA ends to a-NHEJ and presumably HR, resulting in
increased survival after zeocin exposure. In any case, we conclude
that phosphorylations of the PQR and JK sites facilitate the dom-
inant negative phenotype of the ABCDEAla mutant. We specu-
late that, since structural modeling (Fig. 4B) suggests that both JK
and PQR sites may be close to the DNA binding pocket, JK and
PQR phosphorylations may facilitate positioning and/or mainte-
nance of the DNA ends into the DNA-PKcs DNA binding pocket,
restricting access to DNA ends from other repair factors. We sug-
gest that PQR and JK phosphorylations (at least in the absence of
ABCDE phosphorylation) impede phosphorylation-induced dis-
sociation of DNA-PKcs from Ku-bound DNA.
Phosphorylation of sites that result in kinase inactivation fa-
cilitates the ABCDE>Ala dominant negative phenotype. Al-
though phosphorylation in the activation or “t” loop of most pro-
tein kinases induces enzymatic activity, our previous studies
suggest that phosphorylation within DNA-PKcs’s t-loop (T3950,
T site) inactivates the enzyme. More recently, we have also shown
that phosphorylation of the N sites (S56 and S72), which are
highly conserved S-hydrophobic sites at the extreme N terminus,
partially inactivates the enzyme. However, it is unlikely that either
N or T phosphorylation results in DNA-PKcs dissociation from
Ku-bound DNA (11, 17). Thus, DNA-PK can self-inactivate by
multiple mechanisms: (i) phosphorylation of T, (ii) phosphoryla-
tion of N, or (iii) phosphorylation-induced kinase dissociation.
Presumably, a DNA-PKcs molecule inactivated by T or N phos-
phorylation could still dissociate by trans-autophosphorylation of
a synapsed complex.
We next tested the effect of blocking kinase inactivation on the
ABCDE dominant negative phenotype. As can be seen in Fig. 7,
cells expressing either the combined ABCDETAla or
ABCDENAla mutant are more resistant to zeocin than cells
expressing the ABCDEAla mutant. (Three independent
ABCDENAla clones were tested because cells expressing
ABCDENAla are slightlymore zeocin resistant than cells lack-
ing DNA-PKcs; this difference was only notable for one of the
three clones studied.) Minimal coding and signal end joining me-
diated by the ABCDEAla mutant are completely ablated by
blocking T but not N phosphorylation. Sequence analysis of rare
coding joints in cells expressing ABCDETAla shows that
blocking T but not N phosphorylation reverses the severe restric-
tion of end processing imparted by the ABCDEAla mutant (Ta-
ble 1). We are further investigating the basis for these differences
in VDJ recombination phenotypes. However, we can conclude
that T and N phosphorylations facilitate the dominant negative
phenotype of the ABCDEAla mutant.
One possible explanation for these data is that when autophos-
phorylation-induced dissociation is slowed, as is the case when
ABCDE phosphorylation is blocked, kinase inactivation (by T or
Nphosphorylation) facilitates prolongedDNA-PKoccupancy at a
DSB. It follows that blocking either T orN phosphorylationmight
maintain enzymatic activity, allowing phosphorylation of sites
that contribute to complex dissociation that normally works in
conjunction with phosphorylation of ABCDE, thus abrogating
ABCDE’s dominant negative effect.
Phosphorylations adjacent to the ABCDE cluster contribute
to its function. Although the first biochemical feature attributed
to DNA-PK’s autophosphorylation was kinase dissociation (dis-
covered almost 20 years ago) (45), the mechanistic basis for this
process has not been clarified. We have shown previously using
two distinct biochemical approaches (9, 17) that although the
ABCDEAla mutant can undergo phosphorylation-dependent
dissociation from Ku-bound DNA, the ABCDEAla mutant dis-
sociates somewhat more slowly than wild-type DNA-PKcs, thus
implicating ABCDE phosphorylation in kinase disassembly.
However, this effect is completely abrogated by blocking PQR
phosphorylations (17). Dobbs et al. reviewed recent proteomic
phosphorylation studies of DNA-PKcs (5); several independent
studies have shown that 12 additional serine or threonine residues
adjacent to theABCDE cluster are phosphorylated in living cells in
FIG6 Phosphorylation of the PQR and JK sites, which are predicted to be near
the putative DNA binding pocket, is required for the ABCDE phenotype. (A)
Two independent V3 transfectant cell strains expressing wild-type DNA-PKcs
(wt strains 52 and 59), the ABCDEAla mutant (strains 7 and 10), the
ABCDEPQRMAla combination mutant (strains 6 and 7), the
ABCDEJKAla combination mutant (strains 15 and 22), or no DNA-PKcs
(vector strains 5 and 6) were plated at cloning densities into completemedium
containing increasing doses of zeocin as indicated. Colonies were stained after
7 days, and percent survival was calculated. Error bars represent standard error
of the means. The inset shows the level of DNA-PKcs protein expression in
untreated cells as determined by Western blotting of whole-cell extracts ob-
tained from the indicated cell strains. (B) Recombination percentage of the
coding joint substrate pJH290 or signal joint substrate pJH201 in V3 cells
transiently expressing RAG proteins and either wild-type DNA-PKcs, the
ABCDEAla mutant, the ABCDEPQRMAla combination mutant, the
ABCDEJKAla combination mutant, or no DNA-PKcs. Error bars represent
the standard error of the means. Note that the differences between the recombi-
nation efficiencies of the ABCDEAla and the ABCDEPQRMAlamutants
for both coding end joining (P  0.01) and signal end joining (P  0.01) are
statistically significant based on a two-tailed unpaired t test. The difference be-
tween the coding end joining efficiency of the ABCDEAla and the
ABCDEJKAla mutants is statistically significant (P  0.05). However, the
difference between the signal end joining efficiencies of these mutants is not sig-
nificant (P 0.05).
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response to a variety of different genotoxic stressors (5, 6). These
12 additional sites are well conserved and are located within 78
residues (spanning residues 2599 to 2677) included in the region
predicted by PSIPRED to lack secondary structure.We considered
that ABCDE phosphorylation is responsible for kinase dissocia-
tion but that this cluster actually includes additional secondary
sites that can facilitate dissociation if the primary sites cannot be
phosphorylated (because of alanine substitution). Six of these sites
(residues 2599, 2600, 2603, 2615, 2645, and 2649) are within or
just N terminal of the ABCDE cluster. The other six sites (residues
2655, 2671, 2672, 2674, 2675, and 2677) are slightly C terminal.
Three additional constructs were generated: (i) ABCDEEXTAla
introduces alanine substitutions at 12 sites (including the six pre-
viously characterized ABCDE sites) between residues 2599 and
2649; (ii) FG introduces substitutions at six sites between residues
2655 to 2677; (iii) ABCDEEXTFGAla introduces substitutions
at all 18 sites in this region (Fig. 8A; see also Fig. S2A and S3A in the
supplemental material).
We first focused on the ABCDEEXTAla construct that blocks
the additional six sites within and slightly N terminal to the
ABCDE cluster; four of these six sites are S-T/hydrophobic sites,
potentially preferred DNA-PK targets. These new constructs were
generated using a different expression vector; thus, newwild-type,
ABCDEAla, and vector clones stably expressing DNA-PKcs
were generated and used in these experiments. As can be seen in
Fig. 8, cells expressing the ABCDEEXTAla mutant are similarly
sensitive to zeocin as cells expressing the ABCDEAla mutant.
However, the minimal coding end joining mediated by the
ABCDEAlamutant is completely ablated by blocking all 12 sites.
This is the only phosphoblockingDNA-PKcsmutant that imparts
a strong dominant negative effect in zeocin clonogenic assays and
ablates the minimal coding and signal VDJ joining activity ob-
served in cells expressing the ABCDEAla mutant. Coding end
joiningwas so severely reduced (less than 0.4%ofwild-type levels)
that only four joints were isolated in 24 independent assays (data
not shown). These data are consistent with the idea that the addi-
tional six sites can function as back-up sites (if the primary sites
cannot be phosphorylated because of alanine substitution), facil-
itating the minimal c-NHEJ observed in cells expressing the
ABCDEAla mutant.
Elegant studies from Drouet and colleagues have shown that
c-NHEJ factors mobilize to a Triton-insoluble fraction after DNA
damage, presumably reflecting their association with DNA dam-
age during repair (24). We have utilized this assay previously and
found that the ABCDEAla mutant is maintained in this Triton-
insoluble fraction longer than wild-type DNA-PKcs. We per-
formed a similar analysis with cells expressing wild-type,
ABCDEAla, andABCDEEXTAlamutantDNA-PKcs. As can be
seen in Fig. 8D, although wild-type DNA-PKcs is detected in this
fraction immediately after zeocin induced damage, it is absent
from this fraction 24 h after damage. In contrast, both the
ABCDEAla and ABCDEEXTAla mutants are present in this
fraction 24 h postexposure to zeocin. Additional biochemical ap-
proaches will be required to assess whether the ABCDEEXTAla
mutant has amore complete obstruction in autophosphorylation-
induced complex dissociation than the ABCDEAla mutant.
We next tested the effect of blocking the additional six (FG)
sites just C terminal of the ABCDE cluster. It has been reported
that these sites are phosphorylated in living cells in response to a
variety of genotoxic stressors. But unlike the sites within ABCDE,
these sites have also been reported to be phosphorylated during
mitosis (46, 47).None of these sites are S-T/Q target sites, and only
one is S-T/hydrophobic.We tested the effect of blocking FG phos-
phorylation, with and without ABCDEEXT ablation. Cells express-
ing the FGAla mutant are indistinguishable from cells express-
ing wild type DNA-PKcs in both zeocin survival assays and VDJ
recombination assays (see Fig. S2 in the supplemental material).
However, blocking FG phosphorylation reverses the zeocin hy-
persensitivity observed by blocking the ABCDEEXTAla sites (see
FIG7 Phosphorylation of theN andT sites, which regulate enzymatic activity,
is required for the ABCDE phenotype. (A) Two or three independent V3
transfectant cell strains expressingwild-typeDNA-PKcs (wt strains 52 and 59),
the ABCDEAla mutant (strains 7 and 10), the ABCDENAla combina-
tion mutant (strains 6, 7, and 12), the ABCDETAla combination mutant
(strains 3 and 11), or no DNA-PKcs (vector strains 5 and 6) were plated at
cloning densities into completemedium containing increasing doses of zeocin
as indicated. Colonies were stained after 7 days, and percent survival was
calculated. Error bars represent standard error of the means. The inset
shows the level of DNA-PKcs protein expression in untreated cells as de-
termined by Western blotting of whole-cell extracts obtained from the
indicated cell strains. (B) Recombination percentage of the coding joint
substrate pJH290 or signal joint substrate pJH201 in V3 cells transiently
expressing RAG proteins and either wild-type DNA-PKcs, the ABCDEAla
mutant, the ABCDENAla combination mutant, the ABCDETAla
combination mutant, or no DNA-PKcs. Error bars represent the standard
error of the means. Note that the differences between the recombination effi-
ciencies of the ABCDEAla and the ABCDENAla mutants for both cod-
ing joining (P  0.05) and signal end joining (P  0.01) are not statistically
significant based on a two-tailed unpaired t test. However, the differences
between the recombination efficiencies of the ABCDEAla and the
ABCDETAla mutants for both coding end joining (P  0.01) and signal
end joining (P 0.05) are statistically significant.
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FIG 8 Blocking phosphorylation of six additional sites adjacent to the ABCDE cluster maintains the ABCDE phenotype and ablates residual VDJ activity. (A)
Alignment of the DNA-PKcs amino acid sequence adjacent to the ABCDE cluster from eight species. The 12 residues that were changed to alanines in the
ABCDEEXTmutant are highlighted. The appropriate letter indicates the positions of theABCDE sites. (B) Two independentV3 transfectant cell strains expressing
wild-type DNA-PKcs (wt strains 34 and 35), the ABCDEAla mutant(strains 29 and 30), the ABCDEEXTAla mutant(strains 32 and 33), or no DNA-PKcs
(vector strains 17 and 18) were plated at cloning densities into complete medium containing increasing doses of zeocin as indicated. Colonies were stained after
7 days, and percent survival was calculated. Error bars represent standard error of the means. The inset shows the level of DNA-PKcs protein expression in
untreated cells as determined by Western blotting of whole-cell extracts obtained from the indicated cell strains. (C) Recombination percentage of the coding
joint substrate pJH290 or signal joint substrate pJH201 inV3 cells transiently expressingRAGproteins and eitherwild-typeDNA-PKcs, theABCDEAlamutant,
the ABCDEEXTAla mutant, or no DNA-PKcs. Error bars represent the standard error of the means. Note that the differences between the recombination
efficiencies of the ABCDEAla and the ABCDEEXTAla mutants for both coding end joining (P  0.001) and signal end joining (P  0.01) are statistically
significant based on a two-tailed unpaired t test. (D) V3 transfectants expressing either wild type DNA-PKcs, the ABCDEAla mutant, or the ABCDEEXTAla
mutant were treated (or not) with 2mg/ml zeocin for 1 h. Cells were harvested either immediately or after 24 h of culture in freshmedium. The Triton-insoluble
nuclear fraction was isolated and analyzed by Western blotting for the level of expression of phospho-S2056 DNA-PKcs, H2AX, and lamin B. One of three
independent experiments performed with identical results is depicted.
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Fig. S3), suggesting that phosphorylation of these sites is also im-
portant for the dominant negative phenotype. We are continuing
to investigate the potential function of these DNA-PKcs phos-
phorylation events.
DISCUSSION
Several conclusions can be inferred from the data presented here.
First, DNA-PK binds DSBs (or unpaired double-stranded ends)
that result from damage induced by a large variety of DNA dam-
aging agents (for instance, intermediates generated by repair of
DNA interstrand cross-links or DNA ends that result from repli-
cation fork arrest). Given that cells unable to phosphorylate the
ABCDE sites remove cisplatin from their DNA at a lower rate than
cells with or without wild-type DNA-PKcs, it seems likely that
ABCDE phosphorylation is required to disengage DNA-PK (and
attempted NHEJ) from those DNA ends. Consistent with this in-
terpretation, during revision of the manuscript, Zhou and Paull
reported that DNA-PK and MRN (Mre11-Rad50-Nbs1) regulate
end resection and that ABCDE phosphorylation was crucial for
promoting end resection (48). Understanding how DNA-PK dis-
engages from these ends is an important, outstanding question.
Second, these studies suggest that the ABCDEAla mutant
catalyzes defective NHEJ, which is much worse for cell viability
than no NHEJ. Several published results are consistent with im-
paired repair by the ABCDEAla mutant, including the follow-
ing: (i) slow resolution of DSBs (as measured by pulse-field elec-
trophoresis [14]), (ii) increased persistence of H2AX foci after
irradiation (10), and (iii) persistent occupancy at DSBs after laser-
induced damage (41, 49). The impact ofDNA-PKon regulation of
other DNA repair pathways is also evident in the removal of cis-
platin lesions (Fig. 2). The ICP-MS methodology measures re-
moval of all types of cisplatin-DNAdamage, including intrastrand
lesions, which are repaired via NER, and interstrand cross-links,
which are most likely repaired via HR. The reduction in the slow
repair step of the cisplatin lesions may reflect a differential impact
on these various repair and tolerance pathways. Moreover, here
we show that this severely impaired NHEJ requires the enzymatic
activity of DNA-PK; ablating enzymatic activity in the
ABCDEAla mutant actually reverses the observed dominant
negative phenotype.
Many investigators have contributed data supporting the idea
that although DNA-PK is remarkably highly phosphorylated,
ABCDE phosphorylation is central to its function (7–10, 13, 16,
49). The fact that this region is predicted to lack secondary struc-
ture is a new piece of evidence further implicating phosphoryla-
tion within this region as an important molecular switch for con-
trolling DNA-PK’s function. Although the ABCDE cluster is in a
region absent in the crystal structure, from modeling regions ad-
jacent in the primary sequence, it seems likely that the ABCDE
cluster is located at a hinge-like region between the head domain
(FAT/kinase/FATC) and the large ring domain. Hammel et al.
utilized SAXS to analyze solution structures of purified DNA-
PKcs monomers that had been phosphorylated (or not) in vitro
(41). Although in vitro phosphorylation of the enzyme will not
result in uniform phosphorylations, we have shown previously
that under these conditions, sites within the ABCDE cluster are
mostly in the phosphorylated state (up to 90%) (36). SAXS struc-
tures of phosphorylated DNA-PKcs revealed dramatic conforma-
tional changes; changes occurred over the entire structure and
likely resulted from relocation of DNA-PKcs domains rather than
from just remodeling within domains (although changes within
domains were observed as well). The most dramatic effect was
“flattening” of the convex shape (as viewed from the side). The
position of the ABCDE cluster at this hinge region provides a
reasonable basis for implicating phosphorylation of these residues
as being important for facilitating this conformational change.
Finally, based on our data as well as on previously published
reports, we propose the followingmodel (Fig. 9). Cryo-EMstudies
have shown that DNA-PKcs has a more crimped conformation
when binding DNA. We suggest that PQR and JK phosphoryla-
tions within, or proximate to, the putative DNA binding pocket
stabilize this conformation and generate an “engaged” c-NHEJ
complex. Phosphorylations in the ABCDE cluster, which exists as
a disordered, flexible region between the head and ring domains,
promote ordered conformational changes that result in eventual
flattening of the complex, consistent with the SAXS studies of
Hammel et al. (41). It is tempting to speculate that the lack of
secondary structure affords the ABCDEEXT region the ability to
promote conformational changes when phosphorylated to differ-
ent extents at the 12 different sites, which may explain the large
impact that blocking ABCDEEXT phosphorylation has on the en-
zyme’s biological function. These ordered conformational
FIG9 Model ofDNA-PK conformational changes during repair. Coupledwith recent structural data, our results suggest amodel wherebyDNAbinding induces
a clamping of the complex.We suggest that phosphorylations within or adjacent to the putativeDNAbinding domain (PQR/JK) promote initiation ofNHEJ and
a “clamping” of the complex. Phosphorylations of the ABCDE sites, predicted to be located in a disordered region, at a hinge between the two domains, lead to
regulated, conformational changes (flattening the complex) that initially promote NHEJ and eventually disengage NHEJ. If DNA-PK is engaged (via PQR/JK
phosphorylation) but can only slowly dissociate because the six ABCDE sites are blocked, c-NHEJ is slow and results in a dominant negative cellular phenotype
because DNA end access is blocked from other repair factors. Maintaining catalytic activity by blocking sites that inactivate the kinase (T and N) abates this
phenotype because additional sites within the ABCDE cluster (ABCDEEXT) are more likely to be phosphorylated.
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changes could facilitate activation of Artemis, recruitment or po-
sitioning of the ligase complex, and eventual complex dissocia-
tion. Maintaining enzymatic activity, for example, by blocking
kinase inactivation through phosphorylation of the N or T site,
could allow phosphorylation of additional sites in the ABCDEEXT
cluster when the primary sites cannot be phosphorylated. If this
model is correct, it follows that blocking these conformational
changes must account for the severe phenotype observed in living
cells when ABCDEEXT phosphorylation is prohibited.
Extending this model, it is possible that different phosphory-
lations promote distinct conformations at different points in re-
pair. Rivera-Calzada et al. examined DNA-PK structure after
autophosphorylation by cryo-EM techniques (38). These studies
examined structural features of the complete DNA-PK complex.
The resulting images were remarkably heterogeneous, including
heterogeneous DNA-PK dimers as well as heterogeneous Ku
dimers and DNA-PKcs monomers. The heterogeneity of the im-
ages precluded assimilation of three-dimensional images of their
data; consistent with the model presented here, the authors con-
cluded that distinct autophosphorylations may result in distinct
conformations and, in general, that autophosphorylation in-
creased flexibility or plasticity in the observed complexes.
Why are these results important? The ABCDEAla mutant
studies presented here provide a tool that has revealed that
DNA-PK is targeted to DNA ends that result frommany different
types of DNA damaging agents in living cells. From studies pre-
sented in Fig. 1, it can be assumed that DNA-PK affects repair at
collapsed replication forks and at DNA cross-links. Understand-
ing the molecular basis of the role of DNA-PK when it is targeted
to DNA ends that are likely not repairable by c-NHEJ is an impor-
tant question to address. Recently, two reports demonstrated that
disrupting DNA-PK in cells deficient in components of the Fan-
coni anemia (FA) pathway abated the FA phenotype in cells and in
FA-deficient animals (50, 51). It is of considerable interest that the
most prominent phenotype of the ACDAla mouse, in which
three of the five Ser/Thr residues within themouse ABCDE cluster
have been replaced with alanines, generated by Zhang and col-
leagues, is bone marrow failure and, most predominately, eryth-
rocytic lineage failure; these animals actuallymimic the FA patient
phenotypes better than many of the FA-deficient mice (8). These
results are of particular importance if the substantial difference in
DNA-PK levels present in primates versus other animals (50-
fold higher in primates) (52, 53) is considered. This may offer an
explanation not only for themore dramatic phenotype in humans
(versus mice) with Fanconi anemia complementation (FANC)
mutations but also for the remarkably severe phenotype in the
only human patient described to date with inactivating DNA-
PKcs mutations (compared to the phenotypes observed in mice,
dogs, and horses with inactivating DNA-PKcs mutations) (54).
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